Prime Minister Narendra Modi had on Thursday cautioned people against complacency and urged…

The Indian Council of Medical Research Director General Dr Rajiv Bahl has criticised a recently pub…

stockpile of 50 million doses of Covaxin. Dr Vikram Paradkar, Executive Vice President (M…

With the surge in Covid-19 cases globally, and this time the BF.7 variant that is said to be highly…

Bharat Biotech's nasal COVID-19 vaccine iNCOVACC, which was given approval as a booster dose, will …

Business Insider consulted with Dr Vipin M. Vashishtha — former convener, IAP Committee on Imm…

"Big Boost to India's Fight Against COVID-19! Bharat Biotech's ChAd36-SARS-CoV-S COVID-19 (Chimp…

The Hyderabad-based company owns the rights to distribute the vaccine in all markets except USA,…

A meeting of the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation …

"The ideal time for a booster dose is six months after the second dose," Ella stated. Abo…

The WHO, in a tweet, said: "WHO has granted emergency use listing (EUL) to Covaxin, developed by…

The Supreme Court of India has decided it cannot be a “mute spectator” as the number of new COVID-1…

Hyderabad-based Bharat Biotech released phase 3 results of its Covid-19 vaccine — Covaxin — today. …

The supply price of Covaxin to the government of India at Rs 150 a dose is a non-competitive price …

Bharat Biotech CEO Krishna Ella and Serum Institute of India (SII) CEO Adar Poonawalla issued a joi…

In a tweet, Lindner said, Very happy that GER government just decided to recognize WHO-listed Covax…

Benefits like how effective the vaccine is in preventing disease, and risks such as high morta…

Bharat Biotech, the company behind the COVID-19 vaccine COVAXIN, has slashed the price of its vacci…

"We got the ethical approval for initiating the booster dose trial on Wednesday. Registration for …

A preprint is a version of a scientific manuscript posted on a public server prior to formal pe…